Antimicrobial Resistance Research Center, National Institute of Infectious Diseases, Japan.
Department of Bacteriology II, National Institute of Infectious Diseases, Japan.
Jpn J Infect Dis. 2021 Mar 24;74(2):87-96. doi: 10.7883/yoken.JJID.2020.499. Epub 2020 Aug 31.
Japan Nosocomial Infections Surveillance (JANIS) is one of the largest national antimicrobial resistance (AMR) surveillance systems in the world. The JANIS Clinical Laboratory division collects comprehensive specimen-based data from diagnostic microbiology laboratories of participating hospitals to monitor the isolation rate of 11 major bacteria and specific AMR bacteria, and creates antibiograms of approximately 20 bacterial species. Data on the JANIS web database system are also annually tabulated and shared with the WHO Global Antimicrobial Resistance Surveillance System. To create a network of international AMR surveillance systems among Asian countries, Japan is developing an international web database system named ASIan Antimicrobial Resistance Surveillance Network (ASIARS-Net) based on the JANIS system; ASIARS-Net is an open-source database and confidentially available at almost no cost. JANIS continues to evolve in multiple directions; some are discussed at the end of this review.
日本医院感染监测（JANIS）是世界上最大的国家抗菌药物耐药性（AMR）监测系统之一。JANIS 临床实验室部分从参与医院的诊断微生物学实验室收集全面的基于标本的数据，以监测 11 种主要细菌和特定 AMR 细菌的分离率，并创建约 20 种细菌的药敏图。JANIS 网络数据库系统上的数据也每年进行汇总，并与世界卫生组织全球抗菌药物耐药性监测系统共享。为了在亚洲国家之间建立国际 AMR 监测系统网络，日本正在基于 JANIS 系统开发一个名为亚洲抗菌药物耐药性监测网络（ASIARS-Net）的国际网络数据库系统；ASIARS-Net 是一个开源数据库，几乎不需要任何成本即可获得机密性。JANIS 继续向多个方向发展；本文在结尾处讨论了其中的一些方向。
